Presentation is loading. Please wait.

Presentation is loading. Please wait.

Proportion of overall use stratified by age over the study period for (A) cyproterone acetate/ethinylestradiol, (B) levonorgestrel/ethinylestradiol and.

Similar presentations


Presentation on theme: "Proportion of overall use stratified by age over the study period for (A) cyproterone acetate/ethinylestradiol, (B) levonorgestrel/ethinylestradiol and."— Presentation transcript:

1 Proportion of overall use stratified by age over the study period for (A) cyproterone acetate/ethinylestradiol, (B) levonorgestrel/ethinylestradiol and (C) drospirenone/ethinylestradiol. Proportion of overall use stratified by age over the study period for (A) cyproterone acetate/ethinylestradiol, (B) levonorgestrel/ethinylestradiol and (C) drospirenone/ethinylestradiol. Lucía Cea-Soriano et al. J Fam Plann Reprod Health Care 2016;42: Copyright © by the BMJ Publishing Group Ltd & the Faculty of Sexual & Reproductive Healthcare of the Royal College of Obstetricians & Gynaecologists. All rights reserved.


Download ppt "Proportion of overall use stratified by age over the study period for (A) cyproterone acetate/ethinylestradiol, (B) levonorgestrel/ethinylestradiol and."

Similar presentations


Ads by Google